Checkpoint Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Checkpoint Therapeutics Inc
Access all reports
Checkpoint Therapeutics Inc. is a biopharmaceutical company focused on developing immunotherapy and targeted treatments for cancer. The company specializes in monoclonal antibodies and small-molecule inhibitors designed to enhance the immune system’s ability to fight tumors. Its pipeline includes drug candidates for various cancers, advancing through clinical trials and regulatory approvals. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Latest articles
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
Ticker symbol
CKPT
Country
🇺🇸 United States